Cardiff Oncology, Inc. financial data

Symbol
CRDF on Nasdaq
Location
San Diego, CA
Fiscal year end
31 December
Latest financial report
10-Q - Q3 2025 - 06 Nov 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 539% % -5.1%
Debt-to-equity 23% % 2.8%
Return On Equity -77% % -4.4%
Return On Assets -63% % -3.9%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 67,360,564 shares 32%
Common Stock, Shares, Outstanding 67,095,000 shares 38%
Entity Public Float $99,095,121 USD 54%
Common Stock, Value, Issued $7,000 USD 40%
Weighted Average Number of Shares Outstanding, Basic 66,879,000 shares 43%
Weighted Average Number of Shares Outstanding, Diluted 66,879,000 shares 43%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax $500,000 USD -27%
Operating Income (Loss) $53,705,000 USD -16%
Nonoperating Income (Expense) $3,283,000 USD -4.3%
Net Income (Loss) Attributable to Parent $50,422,000 USD -17%
Earnings Per Share, Basic 0 USD/shares 15%
Earnings Per Share, Diluted 0 USD/shares 15%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $10,135,000 USD -22%
Cash, Cash Equivalents, and Short-term Investments $60,600,000 USD 5%
Accounts Receivable, after Allowance for Credit Loss, Current $254,000 USD -59%
Assets, Current $61,801,000 USD 4.2%
Property, Plant and Equipment, Net $666,000 USD -33%
Operating Lease, Right-of-Use Asset $764,000 USD -41%
Other Assets, Noncurrent $549,000 USD -57%
Assets $63,780,000 USD 1.4%
Accounts Payable, Current $2,441,000 USD -47%
Employee-related Liabilities, Current $3,142,000 USD 58%
Accrued Liabilities, Current $11,539,000 USD 61%
Liabilities, Current $14,706,000 USD 17%
Operating Lease, Liability, Noncurrent $284,000 USD -71%
Liabilities $14,990,000 USD 11%
Accumulated Other Comprehensive Income (Loss), Net of Tax $50,000 USD -39%
Retained Earnings (Accumulated Deficit) $422,814,000 USD -14%
Stockholders' Equity Attributable to Parent $48,790,000 USD -1.2%
Liabilities and Equity $63,780,000 USD 1.4%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $12,794,000 USD -65%
Net Cash Provided by (Used in) Financing Activities $107,000 USD
Net Cash Provided by (Used in) Investing Activities $14,584,000 USD -415%
Common Stock, Shares Authorized 150,000,000 shares 0%
Common Stock, Shares, Issued 67,095,000 shares 38%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $27,375,000 USD -813%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $10,135,000 USD -22%
Deferred Tax Assets, Valuation Allowance $48,434,000 USD 24%
Deferred Tax Assets, Gross $48,685,000 USD 23%
Operating Lease, Liability $1,523,000 USD -29%
Depreciation $89,000 USD -12%
Payments to Acquire Property, Plant, and Equipment $80,000 USD 900%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $50,454,000 USD -19%
Lessee, Operating Lease, Liability, to be Paid $1,642,000 USD -32%
Property, Plant and Equipment, Gross $5,068,000 USD 0.38%
Operating Lease, Liability, Current $726,000 USD 2.7%
Lessee, Operating Lease, Liability, to be Paid, Year Two $796,000 USD 2.7%
Lessee, Operating Lease, Liability, to be Paid, Year One $710,000 USD 2.8%
Operating Lease, Weighted Average Discount Rate, Percent 0.07 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $119,000 USD -52%
Lessee, Operating Lease, Liability, to be Paid, Year Three $136,000 USD -83%
Deferred Tax Assets, Operating Loss Carryforwards $27,374,000 USD 17%
Preferred Stock, Shares Authorized 20,000,000 shares 0%
Additional Paid in Capital $471,547,000 USD 12%
Depreciation, Depletion and Amortization $93,000 USD -8.8%
Deferred Tax Assets, Net of Valuation Allowance $0 USD
Share-based Payment Arrangement, Expense $5,636,000 USD 26%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares